Literature DB >> 20423747

Serum glucose and lipid levels in adult congenital heart disease patients.

Efrén Martínez-Quintana1, Fayna Rodríguez-González, Vicente Nieto-Lago, Francisco J Nóvoa, Laura López-Rios, Marta Riaño-Ruiz.   

Abstract

Atherosclerosis has been correlated with known cardiovascular risk factors such as serum glucose or lipid levels. Because congenital heart disease patients tend to survive until adulthood, atherosclerosis has also become a matter of concern in these patients. One hundred fifty-eight congenital heart disease patients and 152 patients selected at random from the population were studied and compared to determine serum glucose, total cholesterol, low-density lipoprotein (LDL) cholesterol, high-density lipoprotein cholesterol, and triglycerides levels. Both groups had similar socioeconomic status levels and the same environmental influences. Significant differences were seen between congenital heart disease patients and the control group, after sex, age, and body mass index adjustment, in fasting plasma glucose (97.7 [94.2-101.2] vs 86.9 [83.2-90.7], P < .001), total cholesterol (171.5 [165.7-177.3] vs 199.8 [90.7-206.0], P < .001), LDL cholesterol (103.9 [98.8-108.8] vs 123.8 [118.5-129.1], P < .001), and high-density lipoprotein cholesterol (48.1 [46.2-50.0] vs 54.2 [52.1-56.2], P < .001) levels. Nonsignificant differences were seen in triglycerides concentrations. Those patients with ventricular septal defect, coarctation of the aorta, and cyanosis had the lowest total cholesterol and LDL cholesterol concentrations. Congenital heart disease patients have lower plasma cholesterol concentrations and higher serum glucose levels than noncongenital ones.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20423747     DOI: 10.1016/j.metabol.2010.03.014

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  12 in total

1.  Relationship between non-osmotic arginine vasopressin secretion and hemoglobin A1c levels in adult patients with congenital heart disease.

Authors:  Tomoaki Murakami; Yoko Horibata; Shigeru Tateno; Yasutaka Kawasoe; Koichiro Niwa
Journal:  Heart Vessels       Date:  2018-11-20       Impact factor: 2.037

2.  Subclinical hypothyroidism in grown-up congenital heart disease patients.

Authors:  Efrén Martínez-Quintana; Fayna Rodríguez-González; Vicente Nieto-Lago
Journal:  Pediatr Cardiol       Date:  2012-11-11       Impact factor: 1.655

3.  Risk Estimates for Atherosclerotic Cardiovascular Disease in Adults With Congenital Heart Disease.

Authors:  George K Lui; Ian S Rogers; Victoria Y Ding; Haley K Hedlin; Kirstie MacMillen; David J Maron; Christy Sillman; Anitra Romfh; Tara C Dade; Christiane Haeffele; Stafford R Grady; Doff B McElhinney; Daniel J Murphy; Susan M Fernandes
Journal:  Am J Cardiol       Date:  2016-09-30       Impact factor: 2.778

Review 4.  Metabolic syndrome and coronary artery disease in adults with congenital heart disease.

Authors:  Koichiro Niwa
Journal:  Cardiovasc Diagn Ther       Date:  2021-04

Review 5.  Current Role of Blood and Urine Biomarkers in the Clinical Care of Adults with Congenital Heart Disease.

Authors:  Saurabh Rajpal; Laith Alshawabkeh; Alexander R Opotowsky
Journal:  Curr Cardiol Rep       Date:  2017-06       Impact factor: 2.931

6.  Lipid and glucose serum levels in children with congenital heart disease.

Authors:  Mehdi Ghaderian; Abdol Rahman Emami-Moghadam; Mohsen Ali Samir; Majid Amin Zadeh; Abdol Hamid Saadi
Journal:  J Tehran Heart Cent       Date:  2014-01-12

7.  Overweight and obesity in children with congenital heart disease: combination of risks for the future?

Authors:  Sandra Mari Barbiero; Caroline D'Azevedo Sica; Daniela Schneid Schuh; Claudia Ciceri Cesa; Rosemary de Oliveira Petkowicz; Lucia Campos Pellanda
Journal:  BMC Pediatr       Date:  2014-10-16       Impact factor: 2.125

8.  Metabolic Syndrome in Adults With Congenital Heart Disease.

Authors:  Jason F Deen; Eric V Krieger; April E Slee; Alex Arslan; David Arterburn; Karen K Stout; Michael A Portman
Journal:  J Am Heart Assoc       Date:  2016-02-12       Impact factor: 5.501

9.  Analysis of Cardiovascular Risk Factors in Adults with Congenital Heart Disease.

Authors:  Ju Ryoung Moon; Jinyoung Song; June Huh; I-Seok Kang; Seung Woo Park; Sung-A Chang; Ji-Hyuk Yang; Tae-Gook Jun
Journal:  Korean Circ J       Date:  2015-08-20       Impact factor: 3.243

Review 10.  Prevalence, Treatment, and Control of Hypercholesterolemia in High Cardiovascular Risk Patients: Evidences from a Systematic Literature Review in Spain.

Authors:  Alex de la Sierra; Xavier Pintó; Carlos Guijarro; José López Miranda; Daniel Callejo; Jesús Cuervo; Rudi Subirà; Marta Rubio
Journal:  Adv Ther       Date:  2015-10-26       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.